Why the study?
Does isoproterenol reverse bupivacaine-induced electrophysiologic toxicity in isolated rabbit hearts?
Does isoproterenol reverse bupivacaine-induced electrophysiologic toxicity in isolated rabbit hearts?
Isoproterenol reverses bupivacaine-induced electrophysiologic abnormalities in an isolated rabbit heart model, suggesting potential therapeutic value for bupivacaine intoxication.
Answers are grounded in this paper and cite their sources.
Should not change management of bupivacaine toxicity; leaves open clinical translation pending human data.
The purpose of this study was to test the hypothesis that isoproterenol could reverse bupivacaine toxicity. In eight isolated rabbit hearts an electrophysiologic evaluation was performed then repeated during infusion of bupivacaine (1 microgram/mL) alone and bupivacaine plus isoproterenol (1-2 micrograms/mL). Bupivacaine alone increased electrocardiographic intervals (P wave, QRS complex, PR, AV, and QTc interval) and refractory periods of the myocardium and atrioventricular junction as well as the Wenckebach cycle and pacing thresholds. The addition of isoproterenol corrected partially or completely all bupivacaine-induced abnormalities, and decreased sinus cycle length, suggesting a potential therapeutic value in the treatment of bupivacaine intoxication.
No takes yet. Share an insight, caveat, or question.
Lacombe et al. (1991) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: